t(4;11) (q21;q23) in acute myeloid leukemia-M0 following treatment [EW92 Protocol] for Ewing's sarcoma Leucemia mielóide aguda-M0 com t(4;11) (q21;q23) após tratamento para sarcoma de Ewing com o protocolo EW92

We report on a 7-year-old girl with Ewing's Sarcoma (ES) who developed a poorly differentiated acute myeloid leukemia (AML-M0) 20 months after beginning the EW92 protocol for the treatment of the primary tumor. She received a total dose of 1500 mg of etoposide, a tumor cumulative radiation dose...

Full description

Bibliographic Details
Main Authors: Terezinha J. Marques Salles, Márcia B. Costa, Vera L. L. Morais, Romualdo J. Filho, Mario H. Magalhães, Maria L. M. Silva, Sandra M. A. Silva, Maria S. Pombo de Oliveira
Format: Article
Language:English
Published: Elsevier 2004-01-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000200010